Search


Swissmedic Scientific Advice: Guidance for Applicants and Marketing Authorisation Holders
Swissmedic has published guidance on MAGHP Scientific Advice, which explains how applicants can obtain scientific advice during the development of medicinal products intended for the Marketing Authorisation for Global Health Products (MAGHP) procedure. The guidance covers regulatory, quality, preclinical, clinical and pharmacovigilance topics. Version 2.0 is valid from 13 August 2026. Purpose of MAGHP Scientific Advice MAGHP scientific advice provides applicants with an oppor

Sharan Murugan
3 hours ago2 min read
